126
Views
0
CrossRef citations to date
0
Altmetric
Research Article

lncRNA GMDS-AS1 Restrains Lung Adenocarcinoma Progression Via Recruiting TAF15 Protein to Stabilize SIRT1 mRNA

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 417-434 | Received 22 Nov 2022, Accepted 11 May 2023, Published online: 13 Jun 2023

References

  • Thai AA , SolomonBJ, SequistLV, GainorJF, HeistRS. Lung cancer. Lancet398(10299), 535–554 (2021).
  • Chalela R , CurullV, EnriquezC, PijuanL, BellosilloB, GeaJ. Lung adenocarcinoma: from molecular basis to genome-guided therapy and immunotherapy. J. Thorac. Dis.9(7), 2142–2158 (2017).
  • Garon EB , HellmannMD, RizviNAet al. Five-year overall survival for patients with advanced non small-cell lung cancer treated with pembrolizumab: results from the phase I KEYNOTE-001 study. J. Clin. Oncol.37(28), 2518–2527 (2019).
  • Mittal V . Epithelial mesenchymal transition in tumor metastasis. Annu. Rev. Pathol.13, 395–412 (2018).
  • Gibbons DL , LinW, CreightonCJet al. Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression. Genes Dev.23(18), 2140–2151 (2009).
  • Jiang L , LiZ, WangR. Long noncoding RNAs in lung cancer: regulation patterns, biologic function and diagnosis implications (review). Int. J. Oncol.55(3), 585–596 (2019).
  • Li J , LiP, ZhaoWet al. Expression of long non-coding RNA DLX6-AS1 in lung adenocarcinoma. Cancer Cell Int.15, 48 (2015).
  • Li J , WangJ, ChenYet al. lncRNA MALAT1 exerts oncogenic functions in lung adenocarcinoma by targeting miR-204. Am. J. Cancer Res.6(5), 1099–1107 (2016).
  • Zhao M , XinXF, ZhangJY, DaiW, LvTF, SongY. lncRNA GMDS-AS1 inhibits lung adenocarcinoma development by regulating miR-96-5p/CYLD signaling. Cancer Med.9(3), 1196–1208 (2020).
  • Bi G , LiangJ, ZhaoMet al. miR-6077 promotes cisplatin/pemetrexed resistance in lung adenocarcinoma via CDKN1A/cell cycle arrest and KEAP1/ferroptosis pathways. Mol. Ther. Nucleic Acids28, 366–386 (2022).
  • Robinson EK , CovarrubiasS, CarpenterS. The how and why of lncRNA function: an innate immune perspective. Biochim. Biophys. Acta Gene Regul. Mech.1863(4), doi:10.1016/j.bbagrm.2019.194419 (2020) (Epub ahead of print).
  • Ren P , XingL, HongX, ChangL, ZhangH. lncRNA PITPNA-AS1 boosts the proliferation and migration of lung squamous cell carcinoma cells by recruiting TAF15 to stabilize HMGB3 mRNA. Cancer Med.9(20), 7706–7716 (2020).
  • Wang J , CaiY, LuH, ZhangF, ZhengJ. lncRNA APOA1-AS facilitates proliferation and migration and represses apoptosis of VSMCs through TAF15-mediated SMAD3 mRNA stabilization. Cell Cycle20(17), 1642–1652 (2021).
  • Lin Z , FangD. The roles of SIRT1 in cancer. Genes Cancer4(3–4), 97–104 (2013).
  • Li X , JiangZ, LiX, ZhangX. SIRT1 overexpression protects non-small cell lung cancer cells against osteopontin-induced epithelial–mesenchymal transition by suppressing NF-κB signaling. Onco. Targets Ther.11, 1157–1171 (2018).
  • Wang AJ , WangS, WangBJet al. Epigenetic regulation associated with sirtuin 1 in complications of diabetes mellitus. Front. Endocrinol. (Lausanne)11, doi:10.3389/fendo.2020.598012 (2020) (Epub ahead of print).
  • Lin CY , TsaiPH, KandaswamiCCet al. Matrix metalloproteinase-9 cooperates with transcription factor snail to induce epithelial–mesenchymal transition. Cancer Sci.102(4), 815–827 (2011).
  • Noh JH , KimKM, McCluskyWG, AbdelmohsenK, GorospeM. Cytoplasmic functions of long noncoding RNAs. Wiley Interdiscip. Rev. RNA9(3), e1471 (2018).
  • Kowluru RA , SantosJM, ZhongQ. Sirt1, a negative regulator of matrix metalloproteinase-9 in diabetic retinopathy. Invest. Ophthalmol. Vis. Sci.55(9), 5653–5660 (2014).
  • Zou SF , PengYH, ZhengCMet al. Octreotide ameliorates hepatic ischemia-reperfusion injury through SNHG12/TAF15-mediated Sirt1 stabilization and YAP1 transcription. Toxicol. Appl. Pharmacol.442, doi:10.1016/j.taap.2022.115975 (2022) (Epub ahead of print).
  • Yang CC , HsiaoLD, TsengHC, KuoCM, YangCM. Pristimerin inhibits MMP-9 expression and cell migration through attenuating NOX/ROS-dependent NF-κB activation in rat brain astrocytes challenged with LPS. J. Inflamm. Res.13, 325–341 (2020).
  • Wang P , ZhuF, KonstantopoulosK. The antagonistic actions of endogenous interleukin-1β and 15-deoxy-Δ12,14-prostaglandin J2 regulate the temporal synthesis of matrix metalloproteinase-9 in sheared chondrocytes. J. Biol. Chem.287(38), 31877–31893 (2012).
  • Hess KR , VaradhacharyGR, TaylorSHet al. Metastatic patterns in adenocarcinoma. Cancer106(7), 1624–1633 (2006).
  • Risolino M , MandiaN, IavaroneFet al. Transcription factor PREP1 induces EMT and metastasis by controlling the TGF-β-SMAD3 pathway in non-small cell lung adenocarcinoma. Proc. Natl Acad. Sci. USA111(36), e3775–e3784 (2014).
  • Chiou SH , WangML, ChouYTet al. Coexpression of oct4 and nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial–mesenchymal transdifferentiation. Cancer Res.70(24), 10433–10444 (2010).
  • Liu B , PanCF, HeZCet al. Long noncoding RNA-LET suppresses tumor growth and EMT in lung adenocarcinoma. Biomed. Res. Int.2016, doi:10.1155/2016/4693471 (2016) (Epub ahead of print).
  • Liu T , YangC, WangW, LiuC. lncRNA SGMS1-AS1 regulates lung adenocarcinoma cell proliferation, migration, invasion, and EMT progression via miR-106a-5p/MYLI9 axis. Thorac. Cancer12(14), 2104–2112 (2021).
  • Xu G , ChenJ, PanQet al. Long noncoding RNA expression profiles of lung adenocarcinoma ascertained by microarray analysis. PLOS ONE9(8), e104044 (2014).
  • Li Z , PanC, WangZet al. lncRNA PCBP1-AS1 correlated with the functional states of cancer cells and inhibited lung adenocarcinoma metastasis by suppressing the EMT progression. Carcinogenesis42(7), 931–939 (2021).
  • Zhang R , XiaT. Long non-coding RNA XIST regulates PDCD4 expression by interacting with miR-21-5p and inhibits osteosarcoma cell growth and metastasis. Int. J. Oncol.51(5), 1460–1470 (2017).
  • Tripathi V , EllisJD, ShenZet al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol. Cell39(6), 925–938 (2010).
  • Wang KC , YangYW, LiuBet al. A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature472(7341), 120–124 (2011).
  • Feng J , BiC, ClarkBS, MadyR, ShahP, KohtzJD. The Evf-2 noncoding RNA is transcribed from the Dlx-5/6 ultraconserved region and functions as a Dlx-2 transcriptional coactivator. Genes Dev.20(11), 1470–1484 (2006).
  • Jiang L , LiJ. lncRNA GMDSAS1 upregulates IL-6, TNF-α and IL-1β, and induces apoptosis in human monocytic THP1 cells via miR-96-5p/caspase 2 signaling. Mol. Med. Rep.25(2), 67 (2022).
  • Ruan X , ZhengJ, LiuXet al. LncRNA LINC00665 stabilized by TAF15 impeded the malignant biological behaviors of glioma cells via STAU1-mediated mRNA degradation. Mol. Ther. Nucleic Acids20, 823–840 (2020).
  • Pan L , LiY, JinL, LiJ, XuA. TRPM2-AS promotes cancer cell proliferation through control of TAF15. Int. J. Biochem. Cell Biol.120, doi:10.1016/j.biocel.2019.105683 (2020).
  • Byles V , ZhuL, LovaasJDet al. SIRT1 induces EMT by cooperating with EMT transcription factors and enhances prostate cancer cell migration and metastasis. Oncogene31(43), 4619–4629 (2012).
  • Cheng F , SuL, YaoCet al. SIRT1 promotes epithelial–mesenchymal transition and metastasis in colorectal cancer by regulating Fra-1 expression. Cancer Lett.375(2), 274–283 (2016).
  • Du L , QianX, LiYet al. Sirt1 inhibits renal tubular cell epithelial–mesenchymal transition through YY1 deacetylation in diabetic nephropathy. Acta Pharmacol. Sin.42(2), 242–251 (2021).
  • Yang H , LiaoD, TongL, ZhongL, WuK. miR-373 exacerbates renal injury and fibrosis via NF-κB/matrix metalloproteinase-9 signaling by targeting sirtuin1. Genomics111(4), 786–792 (2019).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.